Results 71 to 80 of about 1,604 (182)

Alpelisib (Kombination mit Fulvestrant) [PDF]

open access: yes
Diese frühe Nutzenbewertung von Alpelisib (Piqray®) in Kombination mit Fulvestrant ist ein weiteres Verfahren zu einem neuen Arzneimittel beim metastasierten Mammakarzinom.
Bleckmann, Annalen   +3 more
core   +1 more source

Paradigms in Operation: Pharmaceutical Benefit Assessments in England and Germany [PDF]

open access: yes, 2015
The assessment of the benefits of pharmaceutical products through health technology assessments (HTAs) has become a feature of health care decision-making in numerous OECD countries, including England and Germany.
Kieslich, K
core  

Nivolumab (Melanom, adjuvante Therapie, Ablauf Befristung) [PDF]

open access: yes
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie   +1 more
core   +1 more source

Survey to evaluate clinical benefits and acceptance in international tele-intensive care unit collaboration. [PDF]

open access: yesBMC Res Notes
Lezius F   +13 more
europepmc   +1 more source

Avelumab [PDF]

open access: yes
Wörmann, Bernhard   +4 more
core   +5 more sources

Home - About - Disclaimer - Privacy